首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 製藥 > 癌症 > 癌症治療中雙磷酸鹽類藥物與其他骨頭治療藥的功效
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

癌症治療中雙磷酸鹽類藥物與其他骨頭治療藥的功效

Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of Cancer

出版商 Decision Resources, Inc.
出版日期 2005年12月 商品編碼 38475
內容資訊 英文 Pages: 13
價格
本報告書已不再販售

本報告已在2011年07月19日停止出版。

簡介

雙磷酸鹽類藥物已被應用了 25 年之久,一般用治療骨質疏鬆症等骨量減少的疾病。另外也被當做治療帶有這類併發症之癌症的補助藥劑。

專門於醫療產業相關廣泛調查的美國市調公司 Decision Resources Inc. (總公司:麻薩諸塞州),針對癌症治療之雙磷酸鹽類藥物與其他骨頭治療藥的功效進行調查分析,經系統整理後出版報告書 "Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of Cancer" 。

本報告書內容包括:利用雙磷酸鹽類藥物治療之簡介與目前可獲得藥物及其安全性、為治療乳癌及前列腺癌症癌細胞轉移到骨頭及骨量減少該藥劑的功效、針對骨頭疾病的新興非雙磷酸鹽類藥物的資料等。共計 13 頁的內容綱要摘記如下:

序章

雙磷酸鹽類藥物治療之簡介

為了治療癌細胞轉移到骨頭的雙磷酸鹽類藥物

為了治療因乳癌及前列腺癌造成之骨量減少問題的雙磷酸鹽類藥物

做為直接性抗癌藥的雙磷酸鹽類藥物

開發非雙磷酸鹽類癌症治療藥的企業

今後展望

目錄

Abstract

In This Issue...

Bisphosphonates have been in use for approximately 25 years, most commonly to treat diseases characterized by bone loss, such as osteoporosis. Bisphosphonates are also used in adjunctive treatment of cancers that involve bone-related complications. Currently, bisphosphonates are approved only for the treatment of patients with advanced cancer who have bone metastases, but researchers are investigating the direct antitumor effects of these agents and their benefits in treating bone loss resulting from hormonal cancer treatment. In this report, we present an overview of bisphosphonate treatment, including a description of bone remodeling, currently available agents, and safety concerns. We discuss the use of bisphosphonates in the treatment of bone metastases and bone loss in breast and prostate cancer patients and as antitumor agents. We also profile emerging nonbisphosphonate agents that target bone and may pose significant competition for bisphosphonates.

Table of Contents

Introduction

An Overview of Bisphosphonate Treatment

Bisphosphonates to Treat Bone Metastases

Bisphosphonates to Treat Bone Loss in Breast and Prostate Cancer

Bisphosphonates as Direct Antitumor Agents

Companies Developing Nonbisphosphonate Bone- Targeting Cancer Treatments

Outlook

Back to Top